A Prospective Observational Study Reviewing the Incidence of Nail Changes in Patients Receiving Docetaxel- Based Chemotherapy

A Prospective Observational Study Reviewing the Incidence of Nail Changes in Breast Cancer Patients Receiving Docetaxel- Based Chemotherapy

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12609000477224

Enrollment

Registered

2009-06-17

Start date

2009-06-05

Completion date

2010-07-27

Last updated

2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

assessment of nail changes to patients undergoing chemotherapy with taxotere. Nail bed toxicity was assessed by physical examination, questionnaire completion and photographs. Study participation during chemotherapy treatment and up to 3 months post chemotherapy.

Interventions

Observational study of nail changes in patients receiving docetaxel based chemotherapy over approx. 6 months. Dose, mode of administration and frequency of treatment with docetaxel are dependent upon the docetaxel chemotherapy regimen chosen. This will be at the discretion of the clinician and details will be recorded for each treatment cycle .

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Women with early breast cancer receiving adjuvent docetaxel based chemotherapy for at least 3 cycles of chemotherapy.

Exclusion criteria

Serious intercurrent illness or psychological,sociological, geographical conditions which would preclude adequate follow up and compliance with the protocol. Pre-existing nail conditions.

Outcome results